RP
QDEL icon

Riverwater Partners’s QuidelOrtho QDEL Stock Holding History

Riverwater Partners’s Portfolio QDEL Stock Details QDEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-1,886
Closed -$212K – 198
2022
Q1 		$212K Sell
1,886
-66
-3% -$7.03K 0.35% 100
2021
Q4 		$264K Buy
+1,952
New +$272K 0.23% 172

Other funds holding QDEL

CG
Carlyle Group Washington, District of Columbia $10B AUM 10.61% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SM
Senvest Management New York $3.41B AUM 66.27% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
FAM
Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Riverwater Partners's QDEL Position: Q2 2022 in Review

Riverwater Partners sold out of QuidelOrtho (QDEL) in Q2 2022, closing a stake of 1,886 shares — an estimated $212K sold.

Riverwater Partners first reported a position in QDEL in Q4 2021 and held it in 2 quarters. The position peaked at $264K in Q4 2021. 347 funds tracked by Wall St. Rank hold QDEL as of Q2 2022.

  • Riverwater Partners reported no remaining QuidelOrtho position as of Q2 2022 after selling out during the quarter.
  • Riverwater Partners sold 1,886 QuidelOrtho shares in Q2 2022, an estimated $212K.
  • Riverwater Partners first reported a position in QuidelOrtho in Q4 2021 and held it in 2 quarters.
  • Riverwater Partners's QuidelOrtho position peaked at $264K in Q4 2021.
  • 347 funds tracked by Wall St. Rank held QuidelOrtho as of Q2 2022.

Based on Riverwater Partners's 13F filing for Q2 2022, filed 5 Aug 2022.